News: Public Health
Read the latest news from the College of Natural Sciences at The University of Texas at Austin
Coal Power Killed Half a Million People in U.S. over Two Decades
Deaths from coal were highest in 1999, but by 2020 decreased by about 95%, as coal plants have installed scrubbers or shut down.
College Announces Newest Inductees to Hall of Honor
The Hall of Honor recognizes Distinguished Alumni, Distinguished Service and Emerging Leader award winners.
Health Benefits of Wind Power Rely on Which Fossil Fuel Plants It Replaces
Health benefits of using wind energy instead of fossil fuels could quadruple if the most polluting power plants are selected for dialing down, new study...
Seven Natural Sciences Faculty Receive NSF CAREER Awards
Learn about faculty members from UT Austin's College of Natural Sciences who have been awarded CAREER Awards from the National Science Foundation.
Department of Molecular Biosciences
New Vaccine Advances Could Help Against More Viral Illnesses
Jason McLellan and his team advance understanding of human metapneumovirus (hMPV) and human cytomegalovirus (HCMV), which can help them develop vaccines.
New Study Shows How Deep-learning Technology Can Improve Brain Imaging
The technology can be used to train computers to increase the resolution of low-quality cellular and tissue images acquired on point-scanning systems, such as MRI
New Model Can Help Improve COVID-19 Vaccine Distribution
A new model could help public health officials in Central Texas better manage what amounts to a much larger vaccination campaign than was carried out...
UT News
Coronavirus Mutation May Have Made It More Contagious
The virus that causes the coronavirus disease COVID-19 is accumulating genetic mutations, one of which may have made it more contagious.
UT News
Curbing COVID-19 Hospitalizations Requires Attention to Construction Workers
A new study shows how much more likely construction workers are to get diagnosed with COVID-19 compared to non-construction workers
Department of Molecular Biosciences
Locking Down Shape-Shifting Spike Protein Aids Development of COVID-19 Vaccine
An experimental COVID-19 vaccine against SARS-CoV-2 elicits neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered spike protein.